Hagelberg Nora, Jääskeläinen Satu K, Martikainen Ilkka K, Mansikka Heikki, Forssell Heli, Scheinin Harry, Hietala Jarmo, Pertovaara Antti
Turku PET Centre, Turku University Central Hospital and University of Turku, 20520 Turku, Finland.
Eur J Pharmacol. 2004 Oct 1;500(1-3):187-92. doi: 10.1016/j.ejphar.2004.07.024.
We review evidence indicating that the striatum and striatal dopamine D2 receptors are involved in the regulation of pain in humans. Painful stimulation produces an increase in regional cerebral blood flow in the human striatum. Pain is a common symptom in patients with nigrostriatal dopaminergic hypofunction. Positron emission tomography findings show that a low dopamine D2 receptor availability in the striatum of healthy subjects (indicating either a low density of dopamine D2 receptors or a high synaptic concentration of dopamine) is associated with a high cold pain threshold and a low capacity to recruit central pain inhibition by conditioning stimulation. Patients with chronic orofacial pain have higher dopamine D2 receptor availability than their age-matched controls. We propose that the striatal dopamine D2 receptor may be an important target for the diagnosis and treatment of chronic pain.
我们回顾了相关证据,这些证据表明纹状体及纹状体多巴胺D2受体参与了人类疼痛的调节。疼痛刺激会使人类纹状体的局部脑血流量增加。疼痛是黑质纹状体多巴胺能功能减退患者的常见症状。正电子发射断层扫描结果显示,健康受试者纹状体中多巴胺D2受体可用性较低(表明多巴胺D2受体密度较低或多巴胺突触浓度较高)与高冷痛阈值以及通过条件刺激募集中枢性疼痛抑制的能力较低相关。慢性口面部疼痛患者的多巴胺D2受体可用性高于年龄匹配的对照组。我们提出,纹状体多巴胺D2受体可能是慢性疼痛诊断和治疗的重要靶点。